VYNE Therapeutics (VYNE) Selling, General & Administrative (2017 - 2026)
VYNE Therapeutics (VYNE) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 101.25 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.09 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 2.96 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 3.03 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 3.71 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 4.31 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 4.98 Mn |
| Jun 30, 2021 | 4.79 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Dec 31, 2020 | 17.90 Mn |